GS
The Goldman Sachs Group, Inc.
$1,152.07
▲ +1.06%
+$12.07
NYSE · Financial · Capital Markets
The Goldman Sachs Group, Inc.
GS · NYSE · Financial · Capital Markets
$1,152.07
▲ +1.06% · +$12.07 today
fundamentals62.1 /100 vs peers
solid
Revenue growth (TTM)2.6
82% below Sector 5Y avg avgSector 5Y avg: 14.6
EPS growth (TTM)27.0
45% above Sector 5Y avg avg · favorableSector 5Y avg: 18.6
EPS forecast (5Y)11.8
In line with Sector fwd avg avgSector fwd avg: 11.9
EPS next year9.8
solid pace
EPS growth (Q/Q)24.2
strong pace
Compared against sector peers where available.
vs sector peers
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| GSThe Goldman Sachs Group, Inc. | $339.87B | 17.8 | +17.8% | 62 |
| XBISPDR S&P Biotech ETF | $0 | 0.0 | - | 83 |
| SCHWThe Charles Schwab Corporation | $179.34B | 20.4 | +21.2% | 81 |
| NUNu Holdings Ltd. | $67.05B | 21.4 | - | 81 |
| EVREvercore | $12.95B | 18.9 | +47.3% | 79 |
